￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Precautions and safety suggestions while taking vorasidenib-VORANIGO

2026-02-01 22:25:32

Check Details
Analysis of the pharmacological action mechanism and therapeutic principle of eflornithine (IWILFIN)

2026-02-01 22:25:32

Check Details
Important precautions and safety guidance during use of odexibat (Belvi)

2026-02-01 22:25:32

Check Details
The efficacy data of Erdafitinib has been released, and the price difference between domestic and foreign countries is huge. How should patients choose?

2026-02-01 22:25:32

Check Details
Talazoparib 2025 medical insurance reimbursement policy

2026-02-01 22:25:32

Check Details
Out-of-pocket price of Crizotinib after medical insurance in 2025

2026-02-01 22:25:32

Check Details
How to master the usage and dosage of serputinib/serpatinib

2026-02-01 22:25:32

Check Details
Will enasidenib be included in the medical insurance directory in 2025?

2026-02-01 22:25:32

Check Details
How much can avatrombopag/sucoxin increase platelet count?

2026-02-01 22:25:32

Check Details
Are there any risks associated with long-term use of giritinib/segatan?

2026-02-01 22:25:32

Check Details
Differences and comparisons between Midostaurin and Gilitinib

2026-02-01 22:25:32

Check Details
What are the indications for Cabergoline?

2026-02-01 22:25:32

Check Details
Category
相关知识